Google Share on Facebook systemic (redirected fromSystemic therapy) Thesaurus Medical Encyclopedia Wikipedia sys·tem·ic (sĭ-stĕm′ĭk, -stē′mĭk) adj. 1.Of or relating to systems or a system. 2. a.Relating to or affecting the entire body or an entire organism:systemic symptoms; ...
Adjuvant endocrine therapy is a pivotal component of treatment for women with hormone receptor-positive early-stage breast cancer; it delays local and distant relapse and prolongs survival. Patients with ER- and/or PR-positive invasive breast cancers should be considered for adjuvant endocrine therapy...
diffuse large B-cell lymphoma [154,155]. Positive results of CAR-T therapy in hematologic malignancies raised hope for CAR-T therapy against solid tumors [156]. In preclinical studies, engineered GPC3-CAR-T cells could effectively eliminate GPC3-positive HCC cells in HCC xenograft mouse models, ...
ENZYME THERAPY HAS BEEN PROVEN TO BE EFFECTIVE IN REDUCING INFLAMMATION, AND CUREZYM'S ALL NATURAL INGREIDIENTS HELP FIGHT INFLAMMATION WITH NO SIDE EFFECTS. Elderly Patients Degenerative joint inflammation, traumatic arthritis, rheumatoid arthritis, etc. Offce/Home Workers Neck ache, chronic muscle ...
3. Definitive systemic therapy as bladder-sparing strategy for MIBC A subset of patients with MIBC will achieve a pCR with NAC (26%–38%) [3,4,22]. For these patients, the potential to avoid local treatment and its complications is very attractive. However, the feasibility of this approach...
The incorporation of newer agents, now standard for patients with stage IV lung cancer, into the curative therapy paradigm has lagged owing to inefficient trial designs, the lengthy follow-up needed to assess survival end points and a developmental focus on the advanced-stage disease setting. ...
Systemic therapy for psoriasis and the risk of cutaneous infections Systemic treatments are important for patients with moderate‐to‐severe psoriasis; however, they may occasionally cause adverse infectious events. Althoug... Y Higashi,S Imafuku,TK Murotani - 《Journal of Dermatology》 被引量: 0发...
with the drug remaining a cornerstone in the upfront therapy for advanced HCC. The design of clinical trials in this malignancy is complicated by important obstacles related to patient selection, prognostic assessment and the need for endpoints that correlate with improvement in survival outcomes. In...
Biological therapy 有 thalidomide , 是一種血管生成抑制劑 (angiogenesis inhibitor),被發現對肝細胞癌有一定程度的療效(10% 左右),且使用不受hypersplenism 的限制。 主題 惡性淋巴瘤之治療 內容 惡性淋巴瘤的化療原則一般取決於其組織型態之惡性度。低惡性度淋巴瘤在 ...
This randomized clinical trial compares the use of perioperative (neoadjuvant and adjuvant) systemic therapy with cytoreductive surgery and hyperthermic